DAVID SANDAGE: Open Payments
NPI 1083276463 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$130 in 6 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $130
Food & beverage: $130
| Company | Payments | Amount |
|---|---|---|
| Aimmune Therapeutics, Inc. | 1 | $32 |
| AstraZeneca Pharmaceuticals LP | 1 | $27 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $22 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $16 |
| Phathom Pharmaceuticals, Inc. | 1 | $11 |
Products named: ZENPEP, FARXIGA, TRINTELLIX, REXULTI, CAPLYTA, VOQUEZNA.
Industry payments across IN — which companies pay providers there.
